Las Vegas, NV -- (SBWIRE) -- 01/15/2014 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: AuRico Gold Inc (NYSE:AUQ), AEterna Zentaris Inc. (USA) (NASDAQ:AEZS), Zynga Inc (NASDAQ:ZNGA), Dendreon Corporation (NASDAQ:DNDN).
AuRico Gold Inc (NYSE:AUQ) ended its recent business day with the advanced of 4.83% and closed at the price of $4.34 after opening at $4.14. The stock traded during its last trading session with the total volume of 5.33 million shares, as compared to its average volume of 2.24 million shares. AuRico Gold Inc. operates as a gold producer with mines and projects in North America. The company’s core operations include the Young-Davidson gold mine in Northern Ontario, Canada; and the El Chanate mine in Sonora State, Mexico.
Will AUQ Continue To Move Higher? Find out via this report
AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) remained among the day bullish 2.42% and traded with volume of 2.57 million shares in the last session, as 3.45, it faced lowest price of $1.21 during the last trading session whereas its day highest price was $1.29. The company’s total market capitalization is $57.31 million, along with 47.13 million shares outstanding. Aeterna Zentaris Inc. (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds from drug discovery to regulatory approval. Its lead oncology program is an ongoing Phase 3 trial in endometrial cancer with zoptarelin doxorubicin (formerly AEZS-108). Its lead endocrinology product is macimorelin acetate (formerly AEZS-130) for which an NDA has been submitted to the FDA, seeking approval for the marketing and sales of macimorelin acetate as the first orally-administered product that induces growth hormone release to evaluate Adult Growth Hormone Deficiency (AGHD). Its pipeline also encompasses other earlier-stage programs in both oncology and endocrinology.
Will AEZS Continue To Move Higher? Find out via this report
Zynga Inc (NASDAQ:ZNGA) showed 8.50 million shares in volume during the last trading session, while the average trading volume remained 16.01 million shares. The stock kicked off its trading session at $4.02 and closed at $4.06 after rallied 0.74%. Zynga Inc. develops, markets, and operates online social games as live services on the Internet, social networking sites, and mobile platforms in the United States and internationally.
Why Should Investors Buy ZNGA After The Recent Gain? Just Go Here and Find Out
Dendreon Corporation (NASDAQ:DNDN) stock traded during its last trading session with the total traded volume of 5.06 million shares versus its average volume of 4.32 million shares. The company opened its trade at the price of $3.31 and its closing price was $3.30 after gained 1.23% for the day. Dendreon Corporation, a biotechnology company, engages in the discovery, development, and commercialization of novel therapeutics to enhance cancer treatment options for patients.
For How Long DNDN will fight for Profitability? Read This Trend Analysis report
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)